总结一下国内的CP的COVID-19疫苗的要求

首先就是众所周知的CDC要求十一开始所有IV applicants需要fully vaccinated for COVID-19

The Centers for Disease Control and Prevention (CDC) requires all IV applicants and K applicants who are referred for a medical exam to be fully vaccinated for COVID-19 as a part of the medical examination. Unlike other required vaccinations, applicants must complete the entire vaccine series for the medical examination to be considered complete. The new requirements go into effect on October 1, 2021. Should you have any further question on this issue, please visit Centers for Disease Control and Prevention (cdc.gov)  for more information.

那么问题来了，中国大陆没有美国批准的三支疫苗（辉瑞BNT、J&J、moderna），现在出国回国是个很大的问题，很多国家也不是你一去就给打的。
期间有人想到去澳门打疫苗（辉瑞BNT）的办法，澳门回大陆无需隔离，但是我上了澳门ZF网站发现仅对澳门人或有长期签证的人提供疫苗，短期逗留人士自费也不给打，所以这条路也断了。


后来发现其实CDC对IVP的疫苗有个说明的网站，CDC Requirements for Immigrant Medical Examinations: COVID-19 Technical Instructions for Panel Physicians这里我没有法贴link，下面是原文

The COVID-19 vaccines approved for use in these Technical Instructions, hereinafter referred to as “approved COVID-19 vaccines,” are those vaccines authorized for emergency use (EUA) by the US Food and Drug Administration (FDA)external icon or listed for emergency use (EUL) by the World Health Organization (WHO). pdf icon[PDF – 3 pages]external icon If an FDA EUA vaccine becomes licensed for use in the United States, it will continue to be an approved COVID-19 vaccine. If an approved COVID-19 vaccine is available to the applicant in the country where the examination occurs, the applicant must complete the vaccine series and provide documentation to the panel physician in person before completion of the medical examination.

所以其实只要是WHO核准EUL的疫苗都可以，也就是说目前大陆的国药北生（注意不包括武生）和科兴都算，大陆的CP申请人如果目前无法出国打疫苗其实就打这两个之一就行了。

万一你也不是在中国大陆，而是在其他国家，一个WHO认可的疫苗都没有，或者有但是量少打不到，这边也有说明，这种情况可以waive掉疫苗

If none of the approved COVID-19 vaccines are routinely available in the country where the panel physician practices, the “Not routinely available” reason should be documented.  If an approved COVID-19 vaccine is available to the applicant but limited supply would cause significant delay for the applicant to receive it, then this situation would also be considered “Not routinely available.’

那已经打了但不是这两家的呢。打第三针吗？也没法打啊？

s1s1s1s1 发表于 2021-9-14 15:53
那已经打了但不是这两家的呢。打第三针吗？也没法打啊？

这。。。你打的是哪家的？还真不知道怎么办

我之前一直等辉瑞被批，现在看来一直等不到，所以刚去打了北生

habloespanol 发表于 2021-9-14 16:02
这。。。你打的是哪家的？还真不知道怎么办

我之前一直等辉瑞被批，现在看来一直等不到，所以刚去打了 ...

第一针是国药武汉所的

s1s1s1s1 发表于 2021-9-14 16:07
第一针是国药武汉所的

不急的话再等等，WHO可能还是会给EUL的，阿联酋的研究都发表JAMA了，不过比起北生和科兴就总是慢一拍

habloespanol 发表于 2021-9-14 16:17
不急的话再等等，WHO可能还是会给EUL的，阿联酋的研究都发表JAMA了，不过比起北生和科兴就总是慢一拍

嗯 反正横竖也得等

habloespanol 发表于 2021-09-14 01:02:38
这。。。你打的是哪家的？还真不知道怎么办

我之前一直等辉瑞被批，现在看来一直等不到，所以刚去打了北生

听说不过政审是在给国产mrna留时间